Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-7-4
pubmed:abstractText
PGE(2) is a well-known inhibitor of the antidiuretic hormone-induced increase of osmotic water permeability (OWP) in different osmoregulatory epithelia; however, the mechanisms underlying this effect of PGE(2) are not completely understood. Here, we report that, in the frog Rana temporaria urinary bladder, EP(1)-receptor-mediated inhibition of arginine-vasotocin (AVT)-induced OWP by PGE(2) is attributed to increased generation of nitric oxide (NO) in epithelial cells. It was shown that the inhibitory effect of 17-phenyl-trinor-PGE(2) (17-ph-PGE(2)), an EP(1) agonist, on AVT-induced OWP was significantly reduced in the presence of 7-nitroindazole (7-NI), a neuronal NO synthase (nNOS) inhibitor. NO synthase (NOS) activity in both lysed and intact epithelial cells measured as a rate of conversion of l-[(3)H]arginine to l-[(3)H]citrulline was Ca(2+) dependent and inhibited by 7-NI. PGE(2) and 17-ph-PGE(2), but not M&B-28767 (EP(3) agonist) or butaprost (EP(2) agonist), stimulated NOS activity in epithelial cells. The above effect of PGE(2) was abolished in the presence of SC-19220, an EP(1) antagonist. 7-NI reduced the stimulatory effect of 17-ph-PGE(2) on NOS activity. 17-ph-PGE(2) increased intracellular Ca(2+) concentration and cGMP in epithelial cells. Western blot analysis revealed an nNOS expression in epithelial cells. These results show that the inhibitory effect of PGE(2) on AVT-induced OWP in the frog urinary bladder is based at least partly on EP(1)-receptor-mediated activation of the NO/cGMP pathway, suggesting a novel cross talk between AVT, PGE(2), and nNOS that may be important in the regulation of water transport.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/17-phenyltrinorprostaglandin E2, http://linkedlifedata.com/resource/pubmed/chemical/7-nitroindazole, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP, http://linkedlifedata.com/resource/pubmed/chemical/Dibenz(b,f)(1,4)oxazepine-10(11H)-ca..., http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Indazoles, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type I, http://linkedlifedata.com/resource/pubmed/chemical/Oxytocics, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E, EP1..., http://linkedlifedata.com/resource/pubmed/chemical/Vasotocin
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0363-6119
pubmed:author
pubmed:issnType
Print
pubmed:volume
293
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R528-37
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17363677-Animals, pubmed-meshheading:17363677-Blotting, Western, pubmed-meshheading:17363677-Brain Chemistry, pubmed-meshheading:17363677-Calcium, pubmed-meshheading:17363677-Cyclic AMP, pubmed-meshheading:17363677-Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid..., pubmed-meshheading:17363677-Dinoprostone, pubmed-meshheading:17363677-Enzyme Activation, pubmed-meshheading:17363677-Enzyme Inhibitors, pubmed-meshheading:17363677-Epithelial Cells, pubmed-meshheading:17363677-Indazoles, pubmed-meshheading:17363677-Male, pubmed-meshheading:17363677-Nitric Oxide, pubmed-meshheading:17363677-Nitric Oxide Synthase Type I, pubmed-meshheading:17363677-Oxytocics, pubmed-meshheading:17363677-Permeability, pubmed-meshheading:17363677-Rana temporaria, pubmed-meshheading:17363677-Receptors, Prostaglandin E, pubmed-meshheading:17363677-Receptors, Prostaglandin E, EP1 Subtype, pubmed-meshheading:17363677-Signal Transduction, pubmed-meshheading:17363677-Urinary Bladder, pubmed-meshheading:17363677-Vasotocin, pubmed-meshheading:17363677-Water-Electrolyte Balance
pubmed:year
2007
pubmed:articleTitle
Prostaglandin E2 inhibits vasotocin-induced osmotic water permeability in the frog urinary bladder by EP1-receptor-mediated activation of NO/cGMP pathway.
pubmed:affiliation
Laboratory of Renal Physiology, I. M. Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, M. Torez Avenue 44, 194223 St. Petersburg, Russia.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't